AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7368149
Drug: Subcutaneous calcium
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous calcium heparin (2,500 u pre‐operatively then 5,000 u 12‐hourly for 7 days)
Trial: 31989330
Drug: Newly developed
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newly developed extended-release HPMC niacin formulation
Trial: 31989330
Drug: Originator extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Originator extended-release niacin product
Trial: 30297210
Drug: Naftazone 160
RxNorm normalized name: Naftazone
DrugBank: Naftazone (DB13680)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naftazone 160 mg/day
Trial: 28662378
Drug: Flexible lightwand
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible lightwand (Group L)
Trial: 26795957
Drug: Standardized oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized oral health program once yearly between 1 and 3 years of age (Control)
Trial: 24115314
Drug: Bolus calculator
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus calculator and wireless communication between insulin pump and blood glucose metre (Group A)
Trial: 24115314
Drug: Post-prandial glycaemia,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-prandial glycaemia, body mass index-SD score, insulin/kg/24 h (Group A)
Trial: 21499896
Drug: Patupilone combined
RxNorm normalized name: Patupilone
DrugBank: Patupilone (DB03010)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patupilone combined with midazolam 4 mg PO (days 1 and 29)
Trial: 21499896
Drug: Patupilone combined
RxNorm normalized name: Patupilone
DrugBank: Patupilone (DB03010)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patupilone combined with omeprazole 40 mg PO (days 1 and 29)
Trial: 19700170
Drug: Class III
RxNorm normalized name: HLA class III antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class III antiarrhythmic drugs (AADs)
Trial: 19700170
Drug: Not taking
RxNorm normalized name: Lamictal 25mg-100mg Tablet Starter Kit (For Patients Not Taking Enzyme-Inducing Drugs or Valproate)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not taking class III antiarrhythmic drugs (AADs)
Trial: 17915799
Drug: Sodium feredetate
RxNorm normalized name: Sodium feredetate
DrugBank: Sodium feredetate (DB13381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium feredetate (33 mg elemental iron) with vitamin B12 (15 microg) and folic acid (1.5 mg) administered twice a day (Group A)
Trial: 17915799
Drug: Sodium feredetate
RxNorm normalized name: Sodium feredetate
DrugBank: Sodium feredetate (DB13381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium feredetate (66 mg elemental iron) with vitamin B12 (15 microg) and folic acid (1.5 mg) administered twice a day (Group B)
Trial: 17915799
Drug: Ferrous fumarate
RxNorm normalized name: Ferrous Fumarate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous fumarate (100 mg elemental iron) with vitamin B12 (15 microg) and folic acid (1.5 mg) administered twice a day (Group C)
Trial: 15205383
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of [(14)C]capravirine (1400 mg)
Trial: 15205383
Drug: Multiple oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple oral doses of ritonavir (100 mg) followed by a single oral dose of [(14)C]capravirine (1400 mg)
Trial: 9222182
Drug: OPC-14117 240
RxNorm normalized name: OPC-14523
DrugBank: OPC-14523 (DB05422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPC-14117 240 mg per day
Trial: 3662059
Drug: LE +
RxNorm normalized name: Perle +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LE + NaHCO3 (0.1 mEq/ml anesthetic solution)
Trial: 29766318
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate 50 mg tablet once daily
Trial: 16192545
Drug: CSE using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSE using bupivacaine 0.5% for spinal anesthesia and ropivacaine 0.2% with 0.5 microg/mL of sufentanil for postoperative epidural analgesia (CSE; n = 8)
Trial: 8608877
Drug: Mesalamine (Pentasa)
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mesalamine (Pentasa) 4 g . day(‐1)
Trial: 6604081
Drug: Dazoxiben (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dazoxiben (100 mg orally three times once every 4 hr)
Trial: 27574399
Drug: FDC therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC therapy (40 mg olmesartan medoxomil, 20 mg rosuvastatin)
Trial: 27574399
Drug: olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: olmesartan medoxomil (40 mg)
Trial: 27574399
Drug: rosuvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin (20 mg)
Trial: 25048851
Drug: Fosfomycin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosfomycin (2 g/6 hours IV) plus Imipenem (1 g/6 hours IV)
Trial: 11354529
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (200 mg per week)
Trial: 8028614
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (20 mg twice daily for four weeks)
Trial: 2733080
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml of a 10% glucose polymer solution at 20 min intervals during exercise (CHO)
Trial: 1221326
Drug: 5-drug therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-drug therapy (5 FU, methotrexate, vincristine, cyclophosphamide, and prednisone)
Trial: 1221326
Drug: 4-drug therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-drug therapy (5 FU, methotrexate, vincristine, cyclophosphamide)
Trial: 1221326
Drug: 5-drug therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-drug therapy
Trial: 1221326
Drug: 4-drug therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-drug therapy
Trial: 24644541
Drug: Weekly vitamin
RxNorm normalized name: Ezy Dose Weekly Vitamin Planner 2XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly vitamin D supplementation (cholecalciferol; 50,000 units for 12 weeks)
Trial: 20510665
Drug: Prenatal exposure
RxNorm normalized name: Ardisia crenata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal exposure to beta-blocking agents
Trial: 20510665
Drug: Iron supplementation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation, antiemetics, analgesics, antibiotics, or any other main ATC group
Trial: 16707912
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (433 +/- 40 pmol/l)
Trial: 16707912
Drug: No insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No insulin (serum insulin levels suppressed at 14 +/- 1 pmol/l)
Trial: 14629524
Drug: 1 mL
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mL 25% sucrose
Trial: 14629524
Drug: 1 mL
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mL water (placebo)
Trial: 10797125
Drug: Progestin-only oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progestin-only oral contraceptive (OC P)
Trial: 31258136
Drug: 14-day bismuth-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day bismuth-containing quadruple therapy (BQT)
Trial: 31258136
Drug: 10-day moxifloxacin-bismuth-combined
RxNorm normalized name: bismuth preparations, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day moxifloxacin-bismuth-combined treatment (MBCT)
Trial: 31258136
Drug: 14-day moxifloxacin-bismuth-combined
RxNorm normalized name: bismuth preparations, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-day moxifloxacin-bismuth-combined treatment (MBCT)
Trial: 27432383
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with vonoprazan-amoxicillin-clarithromycin
Trial: 27432383
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with vonoprazan-amoxicillin-metronidazole
Trial: 27432383
Drug: Control (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (single therapy)
Trial: 22892157
Drug: ERN (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ERN (2 g/day)
Trial: 22892157
Drug: P‐OM3 (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P‐OM3 (4 g/day)
Trial: 22892157
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (ERN + P‐OM3)
Trial: 20462054
Drug: Shenqi Fuzheng
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenqi Fuzheng Injection (SFI) plus chemotherapy
Trial: 18260838
Drug: Indapamide retard
RxNorm normalized name: Indapamide
DrugBank: Indapamide (DB00808)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indapamide retard 1.5 mg
Trial: 15778862
Drug: Doxycycline (twice-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (twice-daily for 7 days)
Trial: 11835022
Drug: Warfarin in
RxNorm normalized name: warfarin Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin in addition to aspirin
Trial: 2087820
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg ranitidine given after an early evening meal (6 p.m.)
Trial: 2087820
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg ranitidine given at bedtime (10 p.m.)
Trial: 2087820
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg ranitidine (early evening) for patients with ulcer diameter 5 mm to 9.5 mm and a history of duodenal ulcer
Trial: 467056
Drug: Conventional tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional tablet of oral contraceptive
Trial: 23541061
Drug: CGS impregnated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS impregnated with bFGF at 7 or 14 μg/cm(2) after debridement
Trial: 23541061
Drug: CGS impregnated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS impregnated with bFGF (low-dose group)
Trial: 23541061
Drug: CGS impregnated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGS impregnated with bFGF (high-dose group)
Trial: 22128425
Drug: Acupuncture after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture after administration of aspirin 500 mg
Trial: 22128425
Drug: Acupuncture after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture after administration of placebo
Trial: 15051597
Drug: 0.7 g
RxNorm normalized name: Bioflavonoid 700 MG/0.7 GM Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.7 g DHA/d for 3 months
Trial: 26933803
Drug: D-serine administration
RxNorm normalized name: D-Serine
DrugBank: D-Serine (DB03929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-serine administration
Trial: 22801200
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no pulmonary surfactant treatment)
Trial: 20536474
Drug: Barrier cream
RxNorm normalized name: Ceramax Skin Barrier Cream
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Barrier cream application alone
Trial: 9538713
Drug: Fan therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fan therapy directed to the head
Trial: 17999708
Drug: Droperidol (0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (0.625 mg)
Trial: 16831962
Drug: Transdermal estradiol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol, 0.014 mg/d (n = 208)
Trial: 12716083
Drug: Intraperitoneal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal bupivacaine (0.5%); administered at different times: before dissection, after dissection, or both.
Trial: 12716083
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (normal saline); no bupivacaine administered.
Trial: 21443793
Drug: 540,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 540,000 IU (corresponding to 13.5 mg) of cholecalciferol (VITD) dissolved in 45 ml herbal oil
Trial: 18595013
Drug: Oral pouch
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pouch with preserved duodenal passage
Trial: 15777293
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray (40 mg)
Trial: 12080833
Drug: Phenytoin and
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin and Chinese traditional drug-Jiegudan
Trial: 1911606
Drug: TRH administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH administered by a nasal spray of 1 mg, four times daily, for 10 consecutive days starting on day 6 postpartum
Trial: 27775195
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone suppositories (400 mg daily)
Trial: 27775195
Drug: 17-alpha-hydroxyprogesterone caproate
RxNorm normalized name: 17-alpha-hydroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17-alpha-hydroxyprogesterone caproate (17OHP-C) (250 mg i.m. once a week)
Trial: 25995057
Drug: Integrated multi-element
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated multi-element psychosocial intervention (cognitive behavioral therapy, family intervention, and case management)
Trial: 21755338
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of clomiphene citrate (CC)
Trial: 17727573
Drug: Antidiuresis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidiuresis treatment
Trial: 15118640
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) < 5 years
Trial: 15118640
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) > or =5 years
Trial: 9393428
Drug: Dental implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental implants not coated with hydroxyapatite
Trial: 9393428
Drug: Dental implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental implants placed in the maxilla
Trial: 9393428
Drug: Dental implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental implants placed in anterior regions of the jaws
Trial: 9393428
Drug: Dental implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental implants in completely edentulous cases
Trial: 9393428
Drug: Dental implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental implants placed in bone scored as having lower quality
Trial: 28572749
Drug: Pomegranate extract
RxNorm normalized name: Pomegranate Extract
DrugBank: Pomegranate (DB14317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomegranate extract (POMx) 1000 mg
Trial: 26176805
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 25 mg/day for 12 weeks
Trial: 26176805
Drug: Anastrozole (AZ)
RxNorm normalized name: Anastrozole
DrugBank: Anastrozole (DB01217)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anastrozole (AZ) 1 mg/day for 12 weeks
Trial: 23957734
Drug: Active mesalazine
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active mesalazine 1.6 g/day plus Lactobacillus casei subsp. DG placebo (Group M)
Trial: 23957734
Drug: Active Lactobacillus
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Lactobacillus casei subsp. DG 24 billion/day plus mesalazine placebo (Group L)
Trial: 23957734
Drug: Group L
RxNorm normalized name: Blood group Lewis alpha-4-fucosyltransferase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group L (placebo)
Trial: 22012522
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg orally once weekly for six months
Trial: 12859312
Drug: NonACEI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NonACEI treatment (Control)
Trial: 6310464
Drug: Cefotaxime sodium
RxNorm normalized name: Cefotaxime Sodium
DrugBank: Cefotaxime (DB00493)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotaxime sodium at a dose of 6 g/day
Trial: 6310464
Drug: Cefotaxime sodium
RxNorm normalized name: Cefotaxime Sodium
DrugBank: Cefotaxime (DB00493)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotaxime sodium at a dose of 3 g/day
Trial: 31280535
Drug: Sling Treatment
RxNorm normalized name: Sling Small/Medium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sling Treatment (ST)
Trial: 21803872
Drug: American ginseng
RxNorm normalized name: American ginseng
DrugBank: Panax quinquefolius whole (DB14296)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: American ginseng (100 mg, 200 mg, 400 mg/day)
Trial: 16952819
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL ropivacaine 0.5%
Trial: 16952819
Drug: 30 mL
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mL ropivacaine 0.5%
Trial: 16952819
Drug: 40 mL
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL ropivacaine 0.5%
Trial: 27761966
Drug: Occupational Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational Therapy Task-Oriented (TO) intervention for 6 weeks, 3 hours per week
Trial: 24097288
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin plus low-intensity warfarin (LDA + W)
Trial: 24160231
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with daily supplementation of 10,000 IU of vitamin A, 400 mg of vitamin E, and 600 mg of vitamin C (G2)
Trial: 21923449
Drug: Metoprolol ER
RxNorm normalized name: Hydrochlorothiazide-Metoprolol ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol ER 100 mg with paroxetine
Trial: 21923449
Drug: Metoprolol ER
RxNorm normalized name: Hydrochlorothiazide-Metoprolol ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol ER 200 mg with paroxetine
Trial: 21923449
Drug: Metoprolol IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol IR (two 100 mg doses) with paroxetine
Trial: 18312046
Drug: LETS Act!
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LETS Act! (brief behavioral therapy for depression)
Trial: 11079089
Drug: GPW mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GPW mixture (gelatin, Peritrast, and water) administered over an intestinal tube
Trial: 8837238
Drug: 3.75 mg
RxNorm normalized name: zopiclone 3.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg leuprolide depot intramuscularly every 28 days for 24 weeks
Trial: 20032953
Drug: Cereton (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cereton (1000 mg)
Trial: 20032953
Drug: Piracetam (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam (2000 mg)
Trial: 16762944
Drug: Phenylalanine intake
RxNorm normalized name: Phenylalanine
DrugBank: Phenylalanine (DB00120)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylalanine intake of 38 mg . kg(‐1) . d(‐1)
Trial: 16762944
Drug: Phenylalanine intake
RxNorm normalized name: Phenylalanine
DrugBank: Phenylalanine (DB00120)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylalanine intake of 37 mg . kg(‐1) . d(‐1)
Trial: 8665998
Drug: Conventional rapid
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional rapid release preparation of oxipurinol sodium
Trial: 2218006
Drug: Enprofylline 150
RxNorm normalized name: Enprofylline
DrugBank: Enprofylline (DB00824)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprofylline 150 mg bd for 2 weeks, then 300 mg bd for 3 weeks
Trial: 2218006
Drug: Theophylline 150
RxNorm normalized name: theophylline 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 150 mg bd for 2 weeks, then 300 mg bd for 3 weeks